Literature DB >> 21903163

Modelling formulations using gene expression programming--a comparative analysis with artificial neural networks.

E A Colbourn1, S J Roskilly, R C Rowe, P York.   

Abstract

This study has investigated the utility and potential advantages of gene expression programming (GEP)--a new development in evolutionary computing for modelling data and automatically generating equations that describe the cause-and-effect relationships in a system--to four types of pharmaceutical formulation and compared the models with those generated by neural networks, a technique now widely used in the formulation development. Both methods were capable of discovering subtle and non-linear relationships within the data, with no requirement from the user to specify the functional forms that should be used. Although the neural networks rapidly developed models with higher values for the ANOVA R(2) these were black box and provided little insight into the key relationships. However, GEP, although significantly slower at developing models, generated relatively simple equations describing the relationships that could be interpreted directly. The results indicate that GEP can be considered an effective and efficient modelling technique for formulation data.
Copyright © 2011 Elsevier B.V. All rights reserved.

Mesh:

Substances:

Year:  2011        PMID: 21903163     DOI: 10.1016/j.ejps.2011.08.021

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  3 in total

1.  Quality by design approach: application of artificial intelligence techniques of tablets manufactured by direct compression.

Authors:  Buket Aksu; Anant Paradkar; Marcel de Matas; Ozgen Ozer; Tamer Güneri; Peter York
Journal:  AAPS PharmSciTech       Date:  2012-09-06       Impact factor: 3.246

2.  An efficient model for auxiliary diagnosis of hepatocellular carcinoma based on gene expression programming.

Authors:  Li Zhang; Jiasheng Chen; Chunming Gao; Chuanmiao Liu; Kuihua Xu
Journal:  Med Biol Eng Comput       Date:  2018-03-16       Impact factor: 2.602

3.  Artificial neural networks in evaluation and optimization of modified release solid dosage forms.

Authors:  Svetlana Ibrić; Jelena Djuriš; Jelena Parojčić; Zorica Djurić
Journal:  Pharmaceutics       Date:  2012-10-18       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.